Professor Chris Gilfillan is currently Director of Endocrinology at Eastern Health. He oversees an active clinical research program and is currently principle or associate investigator in 11 international clinical trials. He has clinical interests in all aspects of endocrinology and research interests in type 2 diabetes, gestational diabetes, osteoporosis and metabolic bone disease and thyroid cancer. He is a Clinical Professor in the Monash Department of Medicine and the Eastern Clinical School. He is currently principal investigator in a clinical trial of the effectiveness of wearable activity and blood glucose monitors in modifying health-related behaviour in type 2 diabetes. He is supervising a project examining muscle mass and function in hip fracture patients and examining the molecular mechanisms of muscle wasting and sarcopenia in these patients. He is also currently lead investigator in a study examining the role circulating tumour DNA in the management of thyroid and the use of novel combination therapies using SMAC mimetics in the treatment of thyroid cancer. He is a lead investigator in the I-First study of redifferentiation therapy in thyroid cancer. He is also supervising a PhD student documenting the impact of implementing a cloud-based monitoring system for gestational diabetes.